Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: A pilot study

Psychopharmacology Bulletin

Volumn 32, Issue 1, 1996, Pages 95-100

  Berman, Ileana ^a,b,d   Merson, Amalia ^b   Sison, Cecile ^b   Allan, Edward ^b   Schaefer, Clara ^b   Loberboym, Mordechai ^c   Losonczy, Miklos F ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d Taunton State Hospital   (United States)

Author keywords

elderly; regional cerebral blood flow (rCBF); risperidone; schizophrenia; single photon emission computed tomography (SPECT)

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PLACEBO; RISPERIDONE;

AGED; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TEMPORAL CORTEX;

AGED; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029889273     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. American Psychiatric Association. DSM-III-R: Diagnosis and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: The Association 1987.
2. Andreasen, NC; Rezai, K; Allinger, R; Swayze, VW II; Flaum, M; Kirchner, P; Cohen, G; and O'Leary, DS. Hypofrontality in neuroleptic-naive patients and patients with chronic schizophrenia. Assessment with Xenon 133 single photon emission computed tomography and Tower of London. Arch. Gen. Psychiatry 49:943-958, 1992.
3. Blackwood, DHR; Ebmeier, KP; Moiré, WJ; Sharp, CW; Glabus, M; Walker, M; Souza, V; Dunan, JR; and Goodwin, GM. Correlation of regional cerebral blood flow equivalents measured by single photon emission computerized tomography with P300 latency and eye movement abnormality in schizophrenia. Acta Psychiatr. Scand. 90:157-166, 1994.
4. Buchsbaum, MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr. Bull. 16:379-389, 1990.
5. Clerghorn, JM. Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br. J. Psychiatry 157:562-570, 1990.
6. Clerghorn, JM; Garnett, ES; Nahmias, C; et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res. 28:119-133, 1989.
7. DeLisi, LE; Buchsbaum, MS; Holcomb, HH; Langston, KC; King, AC; Kessler, R; Pickar, D; Carpenter, WT Jr; Morihisa, JM; Margolin, R; and Weinberger, DR. Increased temporal lobe glucose use in chronic schizophrenic patients. Biol. Psychiatry 25:835-851, 1989.
8. Ebmeier, KP; Blackwood, DHR; Murray, C; Souza, V; Walker, M; Dougall, N; Moffoot, APR; O'Carroll, RE; and Goodwin, GM. Single-photon emission computed tomography with Tc-99m exametazime in unmedicated schizophrenic patients. Biol. Psychiatry 33:487-495, 1993.
9. Erbas, B; Kumbasar, H; Erbengi, G; and Bekdik, C. Tc-99m HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin. Nucl. Med. 12:904-907, 1990.
10. Folstein, MF; Folstein, SE; and McHugh, PR. "Mini-Mental State": A practical method for grading the cognitive state of patients for clinician. J. Psychiatr. Res. 12:189-198, 1975.
11. Frith, CD; Friston, KJ; Liddle, PF; and Frackowiak, RSJ. A PET study of word finding. Neuropsychologia 29:1137-1148, 1991.
12. Geraud, G; Arne-Bes, MC; and Guell, A. Reversibility of hemodynamic hypofrontality in schizophrenia. J. Cereb. Blood Flow Metab. 7:9-12, 1987.
13. Goldman-Rakic, PS; Selemon, LD; and Schwarz, ML. Dual pathways connecting the dorsal prefrontal cortex with hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12:719-743, 1984.
14. Gunther, W. MRI-SPECT and PET-EEG findings on brain dysfunction in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 16:445-462, 1992.
15. Janssen, PAJ; Niemegeers, CJE; Awouters, F; Schellekens, KHL; Megens, AAHP; and Meert, TF. Pharmacology of risperidone (R64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonist properties. J. Pharmacol. Exp. Ther. 244:685-693, 1988.
16. Kay, SR; Fizbein, A; and Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr. Bull. 13:261-276, 1987.
17. Lewis, SW; Ford, RA; Syid, GM; Reveley, A; and Toone, BK. A controlled study of 99-m Tc-HMPAO single photon emission imaging in chronic schizophrenia. Psychol. Med. 22:27-35, 1992.
18. Leysen, JE; Gommeren, W; Eens, A; de Chaffoy de Courcelles, D; Stoof, JC; and Janssen, PAJ. Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther. 251:238-249, 1989.
19. Losonczy, MF; Berman, I; Sison, C; Allan, E; and Murray, A. SPECT changes in schizophrenic patients during emotional activation task. APA Annual Meeting, New Research Abstracts. Miami, FL, 1995.
20. Mathew, RJ, and Wilson, WH. Cerebral blood flow responses to inhaled carbon dioxide in schizophrenia. Acta Psychiatr. Scand. 81:497-506, 1990.
21. Matsuda, H; Jibiki, I; Kinuya, K; Kinuya, S; Shuke, N; Sumiya, H; Tonami, N; and Hisada, K. Tc-99m HMPAO SPECT analysis of neuroleptic effects of regional brain function. Clin. Nucl. Med. 16:660-664, 1991.
22. Megens, AAHP; Awouters, FHL; and Niemegeers, CJE. Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: A comparison with haloperidol. Psychopharmacology (Berl.) 95:493-496, 1988.
23. Nilsson, A; Risberg, J; Johnason, M; and Gustafson, L. Regional changes of cerebral blood flow during haloperidol therapy in patients with paranoid symptoms. Acta Neurol. Scand. Suppl. 64:478-479, 1977.
24. Paulman, RG; Devous, MD; Gregory, RR; Herman, JH; Jennings, L; Bonte, FJ; Nasrallah, HA; and Raese, JD. Hypofrontality and cognitive impairment in schizophrenia: Dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol. Psychiatry 27:377-399, 1990.
25. Shedlack, KJ; Hunter, R; Wyper, D; McLuskie, R; Fink, G; and Goodwin, GM. The pattern of cerebral activity underlying verbal fluency shown by split-dose single photon emission tomography (SPET or SPECT) in normal volunteers. Psychol. Med. 21:687-696, 1991.
26. Volkow, ND; Wolf, AP; van Gelder, P; Brodie, JD; Overall, JE; Cancro, R; and Gomez-Mont, F. Phenomenological correlates of metabolic activity in 18 patients with schizophrenia. Am. J. Psychiatry 144:151-158, 1987.
27. Weinberger, DR; Berman, KF; Suddath, R; and Torrey, EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic and regional cerebral blood flow study of discordant monozygotic twins. Am. J. Psychiatry 149:890-897, 1992.
28. Weinberger, DR; Berman, KF; Zec, RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43:114-125, 1986.
29. Wolkin, A; Angrist, B; Wolf, A; Brodie, JD; Wolkin, B; Jaeger, J; Cancro, R; and Rotrosen, J. Low frontal glucose utilization in chronic schizophrenia: A replication study. Am. J. Psychiatry 145:251-253, 1988.